Literature DB >> 11238038

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

K A Nath1, J P Grande, J J Haggard, A J Croatt, Z S Katusic, A Solovey, R P Hebbel.   

Abstract

Chronic nephropathy is a recognized complication of sickle cell disease. Using a transgenic sickle mouse, we examined whether oxidative stress occurs in the sickle kidney, the origins and functional significance of such oxidant stress, and the expression of the oxidant-inducible, potentially protective gene, heme oxygenase-1 (HO-1); we also examined the expression of HO-1 in the kidney and in circulating endothelial cells in sickle patients. We demonstrate that this transgenic sickle mouse exhibits renal enlargement, medullary congestion, and a reduced plasma creatinine concentration. Oxidative stress is present in the kidney as indicated by increased amounts of lipid peroxidation; heme content is markedly increased in the kidney. Exacerbation of oxidative stress by inhibiting glutathione synthesis with buthionine-sulfoximine dramatically increased red blood cell sickling in the sickle kidney: in buthionine-sulfoximine-treated sickle mice, red blood cell sickling extended from the medulla into the cortical capillaries and glomeruli. HO activity is increased in the sickle mouse kidney, and is due to induction of HO-1. In the human sickle kidney, HO-1 is induced in renal tubules, interstitial cells, and in the vasculature. Expression of HO-1 is increased in circulating endothelial cells in patients with sickle cell disease. These results provide the novel demonstration that oxidative stress occurs in the sickle kidney, and that acute exacerbation of oxidative stress in the sickle mouse precipitates acute vaso-occlusive disease. Additionally, the oxidant-inducible, heme-degrading enzyme, HO-1, is induced regionally in the murine and human sickle kidney, and systemically, in circulating endothelial cells in sickle patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238038      PMCID: PMC1850341          DOI: 10.1016/S0002-9440(10)64037-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

Review 1.  Sickle cell nephropathy.

Authors:  R J Falk; J C Jennette
Journal:  Adv Nephrol Necker Hosp       Date:  1994

Review 2.  The role of oxidants in progressive renal injury.

Authors:  K A Nath; M Fischereder; T H Hostetter
Journal:  Kidney Int Suppl       Date:  1994-02       Impact factor: 10.545

3.  Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme.

Authors:  S Hayashi; R Takamiya; T Yamaguchi; K Matsumoto; S J Tojo; T Tamatani; M Kitajima; N Makino; Y Ishimura; M Suematsu
Journal:  Circ Res       Date:  1999-10-15       Impact factor: 17.367

4.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

5.  Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease.

Authors:  I Malavé; Y Perdomo; E Escalona; E Rodriguez; M Anchustegui; H Malavé; T Arends
Journal:  Acta Haematol       Date:  1993       Impact factor: 2.195

6.  Effect of pyruvate on oxidant injury to isolated and cellular DNA.

Authors:  K A Nath; H Enright; L Nutter; M Fischereder; J N Zou; R P Hebbel
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

7.  High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.

Authors:  M E Fabry; F Costantini; A Pachnis; S M Suzuka; N Bank; H S Aynedjian; S M Factor; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Comparison of oxygenation measurements in pediatric patients during sickle cell crises.

Authors:  J A Craft; E Alessandrini; L B Kenney; B Klein; G Bray; N L Luban; R Meek; V M Nadkarni
Journal:  J Pediatr       Date:  1994-01       Impact factor: 4.406

9.  A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.

Authors:  M E Fabry; A Sengupta; S M Suzuka; F Costantini; E M Rubin; J Hofrichter; G Christoph; E Manci; D Culberson; S M Factor; R L Nagel
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

10.  Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst.

Authors:  T C Hofstra; V K Kalra; H J Meiselman; T D Coates
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

View more
  78 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

2.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 3.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 4.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

5.  Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets.

Authors:  Matteo Piazza; Gaetana Damore; Barbara Costa; Theresa L Gioannini; Jerrold P Weiss; Francesco Peri
Journal:  Innate Immun       Date:  2010-05-14       Impact factor: 2.680

6.  Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

7.  Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Narayana Murali; Anthony J Croatt; Luis A Juncos; Robert P Hebbel; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 8.  Heme Oxygenase-1 in Kidney Health and Disease.

Authors:  Jeremie M Lever; Ravindra Boddu; James F George; Anupam Agarwal
Journal:  Antioxid Redox Signal       Date:  2016-05-26       Impact factor: 8.401

9.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

10.  Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I.

Authors:  Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.